Special Populations Hepatic insufficiency: Atomoxetine should not be used in patients with pheochromocytoma or a history of pheochromocytoma see section 4.
The heart rate effects could be clinically important in some PM patients. Musculoskeletal and connective tissue disorders. Mechanism of action and Pharmacodynamic effects. Maximal plasma concentrations Cmax are reached approximately 1 to 2 hours after dosing. US residents can call their local poison control center at Mechanism of action and Pharmacodynamic effects Atomoxetine is a highly selective and potent inhibitor of the pre-synaptic noradrenaline transporter, its presumed mechanism of action, without directly affecting the serotonin or dopamine transporters.
Similarly, atomoxetine did not affect the binding of these compounds to human albumin. Pharmacokinetics of atomoxetine and its metabolites in individuals with ESRD suggest that no dose adjustment would be necessary see section 4.
Skip to Content googletag. Asthenia, fatigue, lethargy, chills, feeling jittery, irritability, thirst.
Strattera Drug Imprint
Name of the medicinal product. Your child or teenager may need to be closelywatched for suicidal thoughts and actions or need a change in medicine. To help you remember, take it at the same time s each day. Titanium dioxide E 18 mg: Attention should be paid to monitoring of blood pressure and review of treatment of atomoxetine or anti-hypertensive drugs may be justified in the case of significant changes of blood pressure.
Go to medicine cabinet. Notes Do not share this medication with others. Atomoxetine should be introduced with caution in patients with a history of seizure.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Atomoxetine should be used cautiously with anti-hypertensive drugs.
Reporting of suspected adverse reactions.
Contradictory findings regarding this interaction were found. Enter a custom quantity Set. Musculoskeletal system - Rhabdomyolysis.
Calquence Calquence acalabrutinib is a highly selective, potent, Bruton tyrosine kinase BTK inhibitor for Not all pack sizes may be marketed. Find medicines from the same company. Skin and subcutaneous tissue disorders - Alopeciahyperhidrosis.